Taking supplements of Ubiquinol (Bio Ubiquinol Active QH), active form coenzyme Q10, significantly reduces plaque adhesion and bleeding gums.
Japanese researchers from Nihon University School of Dentistry confirmed the effects of Ubiquinol in improving oral health. The reduced form of coenzyme Q10 was used in a double-blind, placebo-controlled clinical trial. Q10 (present in the mitochondria) is essential for energy production in the form of ATP in every cell in the body. The researchers gave forty-five volunteers with mild to middle degree of periodontal disease (37 men, 8 women, average age: 39.4 years old) ubiquinol (150 mg/day) or a placebo for 2 months. They would examine plaque adhesion, pocket depth, bleeding, gingival recession, foul breath and anti-oxidative activity in saliva before and after one and two months of supplementation.
As a result, after two months of supplementation, they would observe in the ubiquinol group statistically significant improvements in plaque adhesion and bleeding by probing. In addition, they would observe that saliva antioxidant activity increased in the ubiquinol group. Furthermore, the members of this group also had less foul breath. (1)
Periodontal disease (pyorrhea alveolaris) is an inflammatory disease. Periodontal bacteria living in plaque causes periodontal disease. Periodontal disease is widely known to increase oxidative stress in saliva. The degree of periodontal disease is evaluated by measuring periodontal pocket depth, bleeding, gingival recession, foul breath, etc.
Coenzyme Q10 is a vital component in the energy production of the cells. There are two forms of coenzyme Q10; oxidized coenzyme Q10 (ubiquinone) and reduced (ubiquinol) coenzyme Q10. Consequently, our bodies convert coenzyme Q10 from one form to the other inside the body. The active form is available as Bio-Ubiquinol Active QH. We can get coenzyme Q10 from food, however, the human body is also able to synthesize it. Our endogenous coenzyme Q10 synthesis declines from our mid-twenties. A study showed that 65% of those who were unable to feel the effect of using ubiquinone observed an effect when they shifted to ubiquinol.
1. The results were presented at "The 63rd Meeting of the Vitamin Society of Japan" held in Hiroshima on June 4th and 5th, 2011.